Critical shortage of new antibiotics in development against multidrug-resistant bacteria-Time to react is now
- PMID: 21435939
- DOI: 10.1016/j.drup.2011.02.003
Critical shortage of new antibiotics in development against multidrug-resistant bacteria-Time to react is now
Abstract
Two commercial databases (Pharmaprojects and Adis Insight R&D) were queried for antibacterial agents in clinical development. Particular attention was given to antibacterial agents for systemic administration. For each agent, reviewers were requested to indicate whether its spectrum of activity covered a set of selected multidrug-resistant bacteria, and whether it had a new mechanism of action or a new target. In addition, PubMed was searched for antibacterial agents in development that appeared in review articles. Out of 90 agents that were considered to fulfil the inclusion criteria for the analysis, 66 were new active substances. Fifteen of these could be systemically administered and were assessed as acting via a new or possibly new mechanism of action or on a new or possibly new target. Out of these, 12 agents were assessed as having documented in vitro activity against antibiotic-resistant Gram-positive bacteria and only four had documented in vitro activity against antibiotic-resistant Gram-negative bacteria. Of these four, two acted on new or possibly new targets and, crucially, none acted via new mechanisms of action. There is an urgent need to address the lack of effective treatments to meet the increasing public health burden caused by multidrug-resistant bacteria, in particular against Gram-negative bacteria.
Copyright © 2011 Elsevier Ltd. All rights reserved.
Similar articles
-
In vitro antibacterial activity of aminosterols against multidrug-resistant bacteria from patients with cystic fibrosis.J Antimicrob Chemother. 2009 Oct;64(4):810-4. doi: 10.1093/jac/dkp281. Epub 2009 Aug 7. J Antimicrob Chemother. 2009. PMID: 19666647
-
Tigecycline: first of a new class of antimicrobial agents.Pharmacotherapy. 2006 Aug;26(8):1099-110. doi: 10.1592/phco.26.8.1099. Pharmacotherapy. 2006. PMID: 16863487 Review.
-
In vitro activity of XF-73, a novel antibacterial agent, against antibiotic-sensitive and -resistant Gram-positive and Gram-negative bacterial species.Int J Antimicrob Agents. 2010 Jun;35(6):531-6. doi: 10.1016/j.ijantimicag.2010.02.008. Epub 2010 Mar 25. Int J Antimicrob Agents. 2010. PMID: 20346634
-
Conserving antibiotics for the future: new ways to use old and new drugs from a pharmacokinetic and pharmacodynamic perspective.Drug Resist Updat. 2011 Apr;14(2):107-17. doi: 10.1016/j.drup.2011.02.005. Epub 2011 Mar 26. Drug Resist Updat. 2011. PMID: 21440486 Review.
-
In vitro activity of ertapenem: review of recent studies.J Antimicrob Chemother. 2004 Jun;53 Suppl 2:ii11-21. doi: 10.1093/jac/dkh204. J Antimicrob Chemother. 2004. PMID: 15150179 Review.
Cited by
-
A historical overview of bacteriophage therapy as an alternative to antibiotics for the treatment of bacterial pathogens.Virulence. 2014 Jan 1;5(1):226-35. doi: 10.4161/viru.25991. Epub 2013 Aug 13. Virulence. 2014. PMID: 23973944 Free PMC article. Review.
-
Trends and significance of VRE colonization in the ICU: a meta-analysis of published studies.PLoS One. 2013 Sep 27;8(9):e75658. doi: 10.1371/journal.pone.0075658. eCollection 2013. PLoS One. 2013. PMID: 24086603 Free PMC article.
-
Fosfomycin as a potential therapy for the treatment of systemic infections: a population pharmacokinetic model to simulate multiple dosing regimens.Pharmacol Res Perspect. 2018 Feb;6(1):e00378. doi: 10.1002/prp2.378. Pharmacol Res Perspect. 2018. PMID: 29417760 Free PMC article.
-
Targeting Salmonella Typhimurium Invasion and Intracellular Survival Using Pyrogallol.Front Microbiol. 2021 Feb 2;12:631426. doi: 10.3389/fmicb.2021.631426. eCollection 2021. Front Microbiol. 2021. PMID: 33603727 Free PMC article.
-
Thirty-minute screening of antibiotic resistance genes in bacterial isolates with minimal sample preparation in static self-dispensing 64 and 384 assay cards.Appl Microbiol Biotechnol. 2015 Sep;99(18):7711-22. doi: 10.1007/s00253-015-6774-z. Epub 2015 Jul 31. Appl Microbiol Biotechnol. 2015. PMID: 26227406 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical